Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trave

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
Plos Pathogens|August 9, 2018
Human papillomavirus type 16 antagonizes IRF6 regulation of IL-1βMichelle Ainouze, Pauline Rochefort, Peggy Parroche, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 1, 2015
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practiceValeria Cento, Monica Tontodonati, Velia Chiara Di Maio, et al.
Italian Journal of Dermatology and Venereology|April 23, 2024
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergensLuca Stingeni, Leonardo Bianchi, Elena S Caroppo, et al.
Dermatologic Therapy|February 23, 2021
DECISA Project (DErmatology Clinics in Italy: Survey on Alitretinoin): A real-life retrospective cohort multicenter study on 438 subjects with chronic hand eczemaSilvia Ferrucci, Paola Persichini, Massimo Gola, et al.
Clinical and Experimental Dermatology|February 3, 2025
Efficacy and Drug Survival of Tralokinumab in Severe Atopic Dermatitis: An 18-Month Multicenter ExperienceFrancesca Barei, Paolo Calzari, Elena Pezzolo, et al.
Antibodies (Basel, Switzerland)|September 22, 2025
Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective StudyLuca Bettolini, Stefano Bighetti, Silvia Mariel Ferrucci, et al.
Journal of Clinical Medicine|March 27, 2025
Effectiveness of Tralokinumab Across Atopic Dermatitis PhenotypesFrancesca Barei, Paolo Calzari, Elena Pezzolo, et al.
Dermatology and Therapy|July 24, 2025
JAK Inhibitors in Atopic Dermatitis: Does Weight Matter? A Real-World, Nationwide Retrospective Study: IL-AD (Italian Landscape Atopic Dermatitis)Mariateresa Rossi, Stefano Bighetti, Alessandra Narcisi, et al.
The EMBO Journal|August 1, 2025
NRAC controls CD36-mediated fatty acid uptake in adipocytes and lipid clearance in vivoInderjeet Singh, Yasuhiro Onogi, Filipe Menezes, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 29, 2024
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort studyGianluca Avallone, Francesco Cavallo, Annalisa Tancredi, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Plos Pathogens|August 9, 2018
Human papillomavirus type 16 antagonizes IRF6 regulation of IL-1βMichelle Ainouze, Pauline Rochefort, Peggy Parroche, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 1, 2015
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practiceValeria Cento, Monica Tontodonati, Velia Chiara Di Maio, et al.
Italian Journal of Dermatology and Venereology|April 23, 2024
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergensLuca Stingeni, Leonardo Bianchi, Elena S Caroppo, et al.
Dermatologic Therapy|February 23, 2021
DECISA Project (DErmatology Clinics in Italy: Survey on Alitretinoin): A real-life retrospective cohort multicenter study on 438 subjects with chronic hand eczemaSilvia Ferrucci, Paola Persichini, Massimo Gola, et al.
Clinical and Experimental Dermatology|February 3, 2025
Efficacy and Drug Survival of Tralokinumab in Severe Atopic Dermatitis: An 18-Month Multicenter ExperienceFrancesca Barei, Paolo Calzari, Elena Pezzolo, et al.
Antibodies (Basel, Switzerland)|September 22, 2025
Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective StudyLuca Bettolini, Stefano Bighetti, Silvia Mariel Ferrucci, et al.
Journal of Clinical Medicine|March 27, 2025
Effectiveness of Tralokinumab Across Atopic Dermatitis PhenotypesFrancesca Barei, Paolo Calzari, Elena Pezzolo, et al.
Dermatology and Therapy|July 24, 2025
JAK Inhibitors in Atopic Dermatitis: Does Weight Matter? A Real-World, Nationwide Retrospective Study: IL-AD (Italian Landscape Atopic Dermatitis)Mariateresa Rossi, Stefano Bighetti, Alessandra Narcisi, et al.
The EMBO Journal|August 1, 2025
NRAC controls CD36-mediated fatty acid uptake in adipocytes and lipid clearance in vivoInderjeet Singh, Yasuhiro Onogi, Filipe Menezes, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 29, 2024
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort studyGianluca Avallone, Francesco Cavallo, Annalisa Tancredi, et al.
Pageof 15